demonstrated that GARP+ Tregs (Figure 1) were highly infiltrated in tumor tissues in the early stage of lung cancer and exerted immunosuppressive effects through the GARP‐TGF‐β pathway to inhibit Teffs.112. This evidence concerns the gene TGFB1 and lung cancer.